Abbott Laboratories (ABT): Senior Vice President sold ~$203K

~$203K

Approx. value · 1,586 sh @ $128.02

30K

Holds after · shares reported

Traded

Nov 25, 2025

Filed

Nov 25, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 23, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
2. Oct 3, 2025FDAFDA device clearance: Amplatzer Guidewire
3. Oct 6, 2025FDARecall: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400
4. Oct 6, 2025FDARecall: Liberta RC DBS IPG (Implantable Pulse Generator), Model Number 62400
5. Oct 6, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
6. Oct 15, 2025Company filing · Form 8-K · ResultsReported its results
7. Oct 29, 2025FDAFDA device clearance: Seguin Annuloplasty Ring
8. Nov 5, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
9. Nov 13, 2025FDARecall: Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
10. Nov 13, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
11. Nov 18, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
12. Nov 18, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
13. Nov 19, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
14. Nov 24, 2025FDARecall: FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monit…
15. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
16. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
17. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-DI code: 00357599819002 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
18. Nov 25, 2025 · this disclosureInsiderOfficer sold ~$203K of ABT shares in the open market

What came next

1. Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
2. Dec 4, 2025Congress · 1 personMembers of Congress: 2 sales
3. Dec 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
4. Dec 12, 2025Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year“On December 12, 2025, Nita Ahuja, M.D. was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.”
5. Dec 17, 2025FDAFDA device clearance: Amplatzer Piccolo™ Delivery System (9-PDS-04F-045)
6. Dec 18, 2025FDAFDA device clearance: Assert-IQ (DM5100)
7. Dec 18, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
8. Dec 19, 2025FDAFDA device approval: Volt™ PFA System
9. Dec 19, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
10. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
11. Jan 23, 2026Insider · First insider buy since Feb 2021CEO purchased ~$2.01M of ABT shares in the open market
12. Jan 29, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
13. Feb 4, 2026Insider · 1 personInsiders: 2 purchases (~$1.1M)
14. Feb 10, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
15. Feb 13, 2026FDAFDA device clearance: Armada™ 14 NC PTA Catheter
16. Feb 20, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
17. Feb 23, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
18. Mar 2, 2026Insider · 6 peopleInsiders: 6 sales (~$485K)
19. Mar 9, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
20. Mar 13, 2026FDAFDA device clearance: Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Eric Shroff, Senior Vice President

• SEC Form 4 at Abbott Laboratories (ABT)Mar 4, 2026
• SEC Form 4 at Abbott Laboratories (ABT)Mar 5, 2025

The full history of Eric Shroff, Senior Vice President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• House Clerk periodic transaction reportOct 30, 2026
• House Clerk periodic transaction reportOct 27, 2026
• House Clerk periodic transaction reportOct 12, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026

Everything OQRO holds on this company is on its ABT page.